Background Recent research suggests that epigenetic modifications may mediate the
behavioral effects of cannabis, influencing exocannabinnoids' long term effects in cognitive …

Background and Aims Δ9‐tetrahydrocannabinol (THC), the principal psychoactive
component of cannabis, has been implicated in affecting fetal neurodevelopment by readily …

Abstract Background 4− 20% of people report using cannabis during pregnancy, thereby it is
essential to assess the associated risks. There is some evidence that prenatal cannabis …

In recent years, Cannabis use/misuse for treating pregnancy-related symptoms and other
chronic conditions has increased among pregnant women, favored by decriminalization …

Public perception surrounding whether cannabis use is harmful during pregnancy often
diverges greatly from the recommendations of doctors and healthcare providers. In contrast …

Cannabis use has risen dramatically in recent years due to global decriminalization and a
resurgence in the interest of potential therapeutic benefits. While emerging research is …

Background: Twelve separate streams of empirical data make a strong case for cannabis-
induced accelerated aging including hormonal, mitochondriopathic, cardiovascular …

Anxiety disorders are one of the top contributors to psychiatric burden worldwide. Recent
years have seen a dramatic rise in the potential anxiolytic properties ascribed to cannabidiol …

Recent European data facilitate an epidemiological investigation of the controversial
cannabis–cancer relationship. Of particular concern were prior findings associating high …

The increasing prevalence of cannabis use during pregnancy has raised medical concerns,
primarily related to Δ9-tetrahydrocannabinol (THC), which readily crosses the placenta and …